
Claus Lindbjerg Andersen
@clauslindbjerg
Professor, Depart. of Molecular Medicine (MOMA), Aarhus University Hospital and @AarhusUni.
Research focus: colorectal cancer, ctDNA, genomics, gene expression
ID: 1089153765524017152
https://moma.dk/colon-cancer 26-01-2019 13:31:08
173 Tweet
273 Followers
55 Following

The clinical utility of post-operative ctDNA detection using dPCR was investigated in a nationwide Danish 🇩🇰cohort of 851 patients with stage II/III colorectal cancer. Results are reported #openaccess 👇 annalsofoncology.org/article/S0923-… Claus Lindbjerg Andersen Tenna Vesterman Henriksen Dept. of Molecular Medicine 2/2

Shifting Recurrence Patterns May Warrant Risk-Stratified Surveillance for Colorectal Cancer insideprecisionmedicine.com/topics/oncolog… via @clinicalomics A new letter piece by Laura Cowen on our recent paper in JAMA Oncology jamanetwork.com/journals/jamao…


We wish you all a Merry Christmas and Happy New Year! 🎄 Thank you for the amazing collaboration! We look forward to more national research in ctDNA guided cancer treatment in 2024 #ctDNA #CancerResearch Claus Lindbjerg Andersen | Lars Dyrskjøt DCCC | Kræftens Bekæmpelse


Vi har givet tilsagn til 6 ansøgere, der søgte vores ekstraordinære puljemidler målrettet forskning i bedre og mere målrettet kræftopfølgning. Læs hvem der kom gennem nåleøjet: dccc.dk/nyheder/opfolg… -tak til alle ansøgere! #Samarbejdeomkræft Claus Lindbjerg Andersen Peter Christensen



🚨 The risk of colorectal cancer recurrens has decreased! 🚨 📣 Now out in JAMA Oncology A nationwide cohort study using health-data registries. Thanks to CONNECT - Center for Clinical and Genomic Data and all our collaborators at Department of Clinical Epidemiology, Aarhus, AUHsurgery, @RandersHospital, and @HorsensHospital.

🚨 New paper out in International Journal of Cancer 🚨 📝 Incidence of Late Recurrence in CRC 🚻 8,883 UICC stage I-III patients (2004-2013) 📉 5-10 year CIF was low and decreasing ⁉️ No support for prolonged surveillance 🏥 Dept. of Molecular Medicine @AuHsurgery Department of Clinical Epidemiology, Aarhus onlinelibrary.wiley.com/doi/10.1002/ij…

Gratis AUH-foredrag - også online - om strålebehandling og kræft-DNA i blodet ved Klaus Seiersen fra DCPT proton therapy og Claus Lindbjerg Andersen fra Dept. of Molecular Medicine den 27. februar kl 16 fagperson.auh.dk/om-os/oplev-au… ctDNA_DK



Great talk by Nadia Øgaard Nadia Øgaard on lower shedding of tumor DNA by Asymptomatic than symptomatic CRC tumors CNAPS 2024 in Graz Austria



New paper published in International Journal of Cancer addressing the selection of mutations to be used as ctDNA markers 🧬📃 Find the article here: onlinelibrary.wiley.com/doi/10.1002/ij… #ctDNA #CancerResearch Dept. of Molecular Medicine

Together with our large network, we applied MRD-EDGE to CRC (Claus Lindbjerg Andersen), NSCLC (nasser altorki) and BRCA (Samuel Aparicio ), including data sequenced at different centers, with outstanding performance in Neo-adjuvant and post-adjuvant predictions


This was originally submitted in 12/2021. Thanks to collabs and coauthors for investing in this project and sticking with us. NRLlab and @clauslindbjerg were tremendous leaders. Amazing contributions from @notsojunkdna Michael Postow Marcin Imieliński and many others

🚨 New paper out in The Lancet Reg Health-Europe 📝 Risk of Recurrence in early-onset vs. late-onset CRC 📉 Decreasing rates of recurrence from 2004 to 2019 ⁉️ Continued focus on early diagnosis 🧑🧒🧒 Claus Lindbjerg Andersen Rune Erichsen @SunesenKG thelancet.com/journals/lanep…